advertisement

---

Starr MR 15

Showing records 1 to 15 | Display all abstracts from Starr MR

104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Starr MR
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045

---

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Shah SM
American Journal of Ophthalmology 2022; 243: 98-108

---

104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Starr MR
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045

---

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Boopathiraj N
American Journal of Ophthalmology 2022; 243: 98-108

---

104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Huang D; Wong JC
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045

---

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Starr MR; Starr MR
American Journal of Ophthalmology 2022; 243: 98-108

---

104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Wong JC; Patel LG
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045

---

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Dalvin LA; AbouChehade J
American Journal of Ophthalmology 2022; 243: 98-108

---

104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Ammar M; Hsu J
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045

---

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Damento G; Garcia MD
American Journal of Ophthalmology 2022; 243: 98-108

---

104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Sivalingam A; Mehta S
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045

---

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Hodge DO; Bakri SJ
American Journal of Ophthalmology 2022; 243: 98-108

---

104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Ho AC; Kuriyan AE
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045

---

104853 Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections
Sit AJ; Iezzi R
American Journal of Ophthalmology 2022; 243: 98-108

---

104926 Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices
Khan MA; Cohen MN; Xu D; Lee D; Moster MR; Yonekawa Y
Retina (Philadelphia, Pa.) 2022; 42: 2039-2045

---